Medical grade Grazoprevir Intermediate 4 CAS 1028252-16-5 with best price CAS NO.1028252-16-5

NSI-189 is neurogenic research agent that was developed from nicotinamide and pyrazine. Randomized controlled trials have shown that it stimulates neurogenesis or neuronal cell production in the brain. In animal studies, it has also been shown to increase the volume of hippocampus by 20% thereby reversing behavioral symptoms of depression. Such studies have shown that it may be an effective treatment for depression. It is also thought to be a promising treatment for other condition including post-traumatic stress disorder (PTSD), Alzheimer's disease and age-related cognitive problems.

Functions: 

· Improved Memory

· Increased Learning Ability

· Improved Cognitive Processing

· Heightened Reflexes

· Heightened Perception

· Reduced Anxiety

· Reduced Depression

In one of the most well known Russian studies, the effects of noopept supplementation was studied on the rat brain. This included both single and long term (28 days) treatment. Some of the conclusions reached regarding the long term treatment include:

Long term treatment did NOT result in the development of tolerance.

The changes caused by the nootropic supplement may play a role in neural restoration

Neurotrophin synthesis in the hippocampus (which the supplement clearly increased) determines cognitive function, especially delayed memory retrieval

Noopept holds much promise to prevent the development of Alzheimer's in patients with mild cognitive impairment

Dosage

Suggested dosage is 10-30mg daily.

Volumetric measuring devices cannot be used to accurately measure a supplement powder. Due to the potency and nature of this product, you MUST use a scale with resolution of at least 1 milligram (0.001 grams) which you can find in our store.

Packing and shipping